NCT03235050: A reported trial by AstraZeneca
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03235050 |
|---|---|
| Title | A Phase IIb, Randomised, Parallel, Double-Blind Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes Mellitus |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 2, 2017 |
| Completion date | May 3, 2018 |
| Required reporting date | May 3, 2021, midnight |
| Actual reporting date | June 3, 2020 |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | None |